Category Archives: Cell Therapy

The Human Genome Unlocked The Aspen Health Forum, 2009. With the mapping of the human genome complete, scientists are hoping to use stem cell therapy and related interventions to alleviate or even cure diseases. What... By: The Aspen Institute … Continue reading →

Purtier - Live cell therapy PURTIER,...... Please call me for more details... Billy Lock( +6598622915. By: Billy Lock … Continue reading →

Dr. Brentjens on CAR T-Cell Therapy Challenges Renier Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, talks about the challenges of Chimeric Antigen Receptor (CAR) T-Cell... By: OncLiveTV … Continue reading →

Denver Regenerative Medicine - What is regenerative medicine? Dr. Joel Cherdack of Denver Regenerative Medicine explains what regenerative medicine is. He and the hosts discuss the benefits of both PRP (platelet rich plasma) and Stem Cell Therapy. By: Denver Regenerative Medicine … Continue reading →

Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr.PV Mahajan Patient testimonial of Limb Girdle Muscular Dystrophy treated by StemRx Bioscience Solutions Pvt. Ltd. By: StemRx BioScience … Continue reading →

By Trisha Gladd, editor, Pharmaceutical Online and BioProcess Online Follow Me On Twitter @pharmaonline and @bioprocessol As we move into 2015, cell therapy as a viable and profitable market is becoming more of a reality, especially with the increased focus on unmet indications offering the potential for small companies to find their niche in the industry. However, one of the challenges with working with cells, at both the research and clinical level, is the issue of variability that can occur during the thawing of cryopreserved cells. The most common thawing method today is the use of a water bath; however, this method can lead to issues with viability, contamination, and inconsistent results. Because of the sensitivity of the cell samples, it is nearly impossible to completely eliminate variability; however, with standardized handling practices, it can be lowered enough that it will not have an impact on the efficacy of a cell-based therapy. The Risks Of The Water Bath Dr. Karim Lee has been working in the Transplantation Research Lab at the Universityof California, San Francisco since 2008 studying the application of regulatory T cells in order to establish long-term acceptance of transplanted organs. Conventionally, we have used the water bath-based … Continue reading →

Parkinson's Disease: Mr Garnet's experience 6 months after stem cell therapy by Harry Adelson, N.D. At Docere Clinics, our clinical focus is on the treatment of musculoskeletal pain disorders. On rare occasions, we have patients, usually relatives of satisf... By: Harry Adelson, N.D. … Continue reading →

Godfrey Flies Cyberquad, Instrumental by Goodie Mob, Cell Therapy Unmaned Aerial Vehicle, the Cyberquad flown by Godfrey Dimau. Suva Fiji Islands. By: Chloe Wong … Continue reading →

Regulatory News: TxCell SA (Paris:TXCL) (FR0010127662 TXCL), a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present at the Cell & Gene Therapy Forum 2015, January 26-28, 2015 at Grand Hayatt in Washington DC, United States. Dr Fortes presentation will be on critical success factors for a successful transition of cell therapy candidates to the clinic. The presentation is scheduled for Monday, January 26, 2015 at 14.30 p.m. EST. A roundtable debate discussing the most important topics raised will follow the presentation. Dr. Forte will use as examples TxCells lead product candidate, Ovasave and second product candidate, Col-Treg from TxCells innovative proprietary ASTrIA technological platform. Ovasave is targeted at refractory Crohns disease and is currently evaluated in a placebo-controlled phase IIb study. Col-Treg is in development for the rare eye disease autoimmune uveitis. Col-Treg is planned to move into a first clinical study in the first half of 2015. The key elements in the presentation include gathering strong pre-clinical and preliminary clinical data. Dr. Forte will also cover key process development … Continue reading →

A Winnipeg-based company that has touted its ability to improve the lives of Multiple Sclerosis patients through stem cell therapy is now under the microscope after allegations of fraud from a client. The CEO of Regenetek Research Inc. has been collecting thousands of dollars from Canadian patients looking for help. Some of the patients are now questioning the research and credentials of the man they know as Dr. Doug. One of them is Lee Chuckry, 47. He has been living with MS for nearly two decades. MS just keeps progressing, thats what it does. Hopefully I could stop it. That was my ultimate goal, Chuckry said in an interview with CTV News. His efforts led him to Regenetek, and its CEO: Doug Broeska. In testimonials, MS patients attributed miraculous medical improvement to experimental stem cell therapy. For $35,000, Regenetek patients were flown to India for the procedure. Chuckry was one of the participants. But when he returned home, he says his symptoms worsened. When he started digging deeper, he said, he found the doctor hed put his faith in wasnt what he claimed to be. Im going to call Doug a con artist, Chuckry said. You are preying on people … Continue reading →